Systemic treatment of non-small cell lung cancer brain metastases

In the systemic treatment of brain metastases from non-small cell lung cancer (BMF-NSCLC) chemo- and targeted therapy are used. Response rates after platinum-based chemotherapy, range from 23% to 45%. Development of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): gefitinib o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Contemp Oncol (Pozn)
Main Authors: Cedrych, Ida, Kruczała, Maksymilian A., Walasek, Tomasz, Jakubowicz, Jerzy, Blecharz, Paweł, Reinfuss, Marian
Formato: Artigo
Idioma:Inglês
Publicado em: Termedia Publishing House 2016
Assuntos:
Review Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5371701/
https://ncbi.nlm.nih.gov/pubmed/28373815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2016.64593
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados